Adverum Biotechnologies Inc’s recent filing unveils that its Director Lupher, Jr. Mark L. acquired Company’s shares for reported $0.18 million on Feb 07 ’24. In the deal valued at $1.35 per share,130,000 shares were bought. As a result of this transaction, Lupher, Jr. Mark L. now holds 130,000 shares worth roughly $1.36 million.
Then, Scopa James Paul bought 100,000 shares, generating $135,000 in total proceeds. Upon buying the shares at $1.35, the Director now owns 100,000 shares.
Before that, Seyedkazemi Setareh sold 6,201 shares. Adverum Biotechnologies Inc shares valued at $9,429 were divested by the Chief Development Officer at a price of $1.52 per share. As a result of the transaction, Seyedkazemi Setareh now holds 47,674 shares, worth roughly $0.5 million.
H.C. Wainwright initiated its Adverum Biotechnologies Inc [ADVM] rating to a Buy in a research note published on April 30, 2024; the price target was $30. A number of analysts have revised their coverage, including Truist’s analysts, who increased its forecast for the stock in early July from “a Hold” to “a Buy”. Cantor Fitzgerald also remained covering ADVM and has decreased its forecast on July 23, 2021 with a “Neutral” recommendation from previously “an Overweight” rating. SVB Leerink revised its rating on May 03, 2021. It rated ADVM as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of ADVM
On Friday, Adverum Biotechnologies Inc [NASDAQ:ADVM] saw its stock jump 4.30% to $10.43. Over the last five days, the stock has gained 13.49%. Adverum Biotechnologies Inc shares have risen nearly 38.55% since the year began. Nevertheless, the stocks have risen 35.45% over the past one year. While a 52-week high of $29.70 was reached on 02/08/24, a 52-week low of $7.40 was recorded on 01/02/24. SMA at 50 days reached $14.49, while 200 days put it at $13.44. A total of 0.9 million shares were traded, compared to the trading of 0.37 million shares in the previous session.
Levels Of Support And Resistance For ADVM Stock
The 24-hour chart illustrates a support level at 10.06, which if violated will result in even more drops to 9.68. On the upside, there is a resistance level at 10.75. A further resistance level may holdings at 11.06. The Relative Strength Index (RSI) on the 14-day chart is 36.93, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.36, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 48.69%. Stochastics %K at 39.38% indicates the stock is a holding.
